Skip to main content

Advertisement

Log in

Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families

  • Movement Disorders (M Okun, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is a chronic progressive neurodegenerative and multidimensional disease that involves a range of disabling motor and nonmotor symptoms. These symptoms can have a major impact on the quality of life of PD patients. The focus of this article is to stress the importance of the interdisciplinary team intervention approach in the treatment of patients with PD. The team approach uses experts in PD from different health care professions, including a neurologist, a nurse, a speech and language therapist, a physiotherapist, a social worker, a psychiatrist, an occupational therapist, a sexologist, and a dietician. The major aim of the team and of teamwork is to provide professional care in all motor and nonmotor aspects of PD throughout the course of the disease. There are different models of multidisciplinary teams: inpatient facility, community rehabilitation facility, and synchronized multiprofessional treatment in the community. The Tel Aviv Sourasky Medical Center model of interdisciplinary care was designed to create a coordinated multidisciplinary team in the Movement Disorders Unit. The role of each team member and their professional objective are described. Their collaboration is by design a promotion of a team goal for maintaining and enhancing the quality of life of PD patients and their families.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Lee AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet. 2009;373(9680):2055–66.

    Article  Google Scholar 

  2. Valkovic P, Abrahamova D, Hlavacka F, Benetin J. Static posturography and infraclinical postural instability in early-stage Parkinson’s disease. Mov Disord. 2009;24:1713–4.

    Article  PubMed  Google Scholar 

  3. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21:916–23.

    Article  PubMed  Google Scholar 

  4. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24:1641–9.

    Article  PubMed  Google Scholar 

  5. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000;69:584–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord. 2008;23:1420–7.

    Article  PubMed  Google Scholar 

  7. Roland KP, Jenkins ME, Johnson AM. An exploration of the burden experienced by spousal caregivers of individuals with Parkinson’s disease. Mov Disord. 2010;25:189–93.

    Article  PubMed  Google Scholar 

  8. Poewe W, Mahlknecht P. The clinical progression of Parkinson’s disease. Parkinsonism Relat Disord. 2009;15 Suppl 4:S28–32.

    Article  PubMed  Google Scholar 

  9. Sinforiani E, Zangaglia R, Manni R, Cristina S, Marchioni E, Nappi G, et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson’s disease. Mov Disord. 2006;21:462–6.

    Article  PubMed  Google Scholar 

  10. Adams D, Richfield E, Johnson M, Jones E, Campbell C. A specialist palliative care service for Parkinson’s disease: review of end of life outcomes. BMJ Support Palliat Care. 2014;4 Suppl 1:A107. This article introduces the concept of palliative care in PD, which is relatively new and very important for the intervention program in advanced PD.

    Article  Google Scholar 

  11. Rodríguez-Violante M, Camacho-Ordoñez A, Cervantes-Arriaga A, González-Latapí P, Velázquez-Osuna S. Factors associated with the quality of life of subjects with Parkinson’s disease and burden on their caregivers. Neurologia. 2014. doi:10.1016/j.nrl.2014.01.008. This article develops the concept of the involvement of caregivers in the treatment of PD patients and its relation to the quality of life.

    PubMed  Google Scholar 

  12. Kalf H, Sturkenboom I, Thijssen M, de Swart B, Bloem B, Munneke M. Pursuing best practice in multidisciplinary care. EPPN J. 2008;14:12–5.

    Google Scholar 

  13. Gibberd FB, Page NG, Spencer KM, Kinnear E, Hawksworth JB. Controlled trial of physiotherapy and occupational therapy for Parkinson’s disease. Br Med J (Clin Res Ed). 1981;282(6271):1196.

    Article  CAS  Google Scholar 

  14. van der Marck MA, Kalf JG, Sturkenboom IH, Nijkrake MJ, Munneke M, Bloem BR. Multidisciplinary care for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15 Suppl 3:S219–23.

    Article  PubMed  Google Scholar 

  15. Post B, van der Eijk M, Munneke M, Bloem BR. Multidisciplinary care for Parkinson’s disease: not if, but how! Pract Neurol. 2011;11(2):58–61. This article stresses the importance of the early involvement of multidisciplinary care in the course of PD.

    Article  PubMed  CAS  Google Scholar 

  16. van der Marck MA. The many faces of Parkinson ’s disease: towards a multifaceted approach? Doctoral thesis. Donders Institute, Radboud University Nijmegen. 2013. This thesis explains the effectiveness of the multimodal approach to the management of PD in accordance with the different clinical symptoms of the disease.

  17. Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80(21):1989–96. doi:10.1212/WNL.0b013e318293e2ce.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, et al. Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up. Neurorehabil Neural Repair. 2012;26(2):144–50. doi:10.1177/1545968311416990.

    Article  PubMed  Google Scholar 

  19. Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, et al. The natural history of treated Parkinson’s disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry. 2011;82:1112–8.

    Article  PubMed  Google Scholar 

  20. Troeung L, Egan SJ, Gasson N. A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease. BMC Psychiatr. 2014;14:19. doi:10.1186/1471-244X-14-19.

    Article  Google Scholar 

  21. Keus SH, Oude Nijhuis LB, Nijkrake MJ, Bloem BR, Munneke M. Improving community healthcare for patients with Parkinson’s disease: the Dutch model. Parkinsons Dis. 2012. doi:10.1155/2012/543426.

    PubMed  PubMed Central  Google Scholar 

  22. Giladi N. Multidisciplinary team work can improve the care of families with Parkinson’s disease. Touch Medical Media. 2011. http://www.touchneurology.com/articles/multidisciplinary-team-work-can-improve-care-families-parkinson-s-disease. This article provides a brief review of the multiprofessional teamwork model of the Movement Disorders Unit at Tel Aviv Sourasky Medical Center.

  23. Keus SH, Bloem BR, Hendriks EJ, Bredero‐Cohen AB, Munneke M. Evidence‐based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research. Mov Disord. 2007;22(4):451–60.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the support of the National Parkinson Foundation Center of Excellence funding which supported the programs reviewed in this article.

Compliance with Ethics Guidelines

Conflict of Interest

Nir Giladi declares the receipt of fees for providing expert testimony for GlaxoSmithKline about impulse control disturbances in Parkinson’s disease, the receipt of grant money, paid to his institution, from the Michael J. Fox Foundation, the National Parkinson Foundation, the European Union Seventh Framework Programme, the Israel Science Foundation, and TEVA Innovative, and the receipt of honoraria from Teva-Lundbeck, Novartis, UCB, and MDS.

Yael Manor declares the receipt of travel expense reimbursement from the World Parkinson Congress (2013, Montreal, Canada).

Ariela Hilel declares the receipt of travel expense reimbursement from the World Parkinson Congress (2013, Montreal, Canada).

Tanya Gurevich declares the receipt of grants, paid to her institution, from the Michael J. Fox Foundation and the National Parkinson Foundation, as well as the receipt of travel expense reimbursement from the World Parkinson Congress in 2013 and the Movement Disorders Congress in 2013 and 2014.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nir Giladi.

Additional information

This article is part of the Topical Collection on Movement Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giladi, N., Manor, Y., Hilel, A. et al. Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families. Curr Neurol Neurosci Rep 14, 493 (2014). https://doi.org/10.1007/s11910-014-0493-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-014-0493-1

Keywords

Navigation